Goldman Sachs’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $343K | Buy |
264,088
+30,498
| +13% | +$44.4K | ﹤0.01% | 5938 |
|
|
2026
Q1 | $339K | Sell |
233,590
-98,364
| -30% | -$156K | ﹤0.01% | 5832 |
|
|
2025
Q4 | $458K | Buy |
331,954
+110,047
| +50% | +$230K | ﹤0.01% | 5643 |
|
|
2025
Q3 | $606K | Sell |
221,907
-221,011
| -50% | -$785K | ﹤0.01% | 5382 |
|
|
2025
Q2 | $1.55M | Sell |
442,918
-187,475
| -30% | -$740K | ﹤0.01% | 4377 |
|
|
2025
Q1 | $2.32M | Buy |
630,393
+610,014
| +2,993% | +$2.23M | ﹤0.01% | 4026 |
|
|
2024
Q4 | $32.8K | Buy |
+20,379
| New | +$21.2K | ﹤0.01% | 5867 |
|
|
2024
Q2 | – | Sell |
-11,846
| Closed | -$56.4K | – | 5908 |
|
|
2024
Q1 | $56.4K | Sell |
11,846
-4,018
| -25% | -$14.1K | ﹤0.01% | 5313 |
|
|
2023
Q4 | $46K | Sell |
15,864
-333
| -2% | -$525 | ﹤0.01% | 5384 |
|
|
2023
Q3 | $21.9K | Sell |
16,197
-13,952
| -46% | -$24.4K | ﹤0.01% | 5352 |
|
|
2023
Q2 | $64.8K | Sell |
30,149
-10,746
| -26% | -$26.1K | ﹤0.01% | 5431 |
|
|
2023
Q1 | $119K | Sell |
40,895
-5,038
| -11% | -$25.4K | ﹤0.01% | 5429 |
|
|
2022
Q4 | $316K | Sell |
45,933
-140,651
| -75% | -$664K | ﹤0.01% | 5115 |
|
|
2022
Q3 | $593K | Sell |
186,584
-16,520
| -8% | -$60K | ﹤0.01% | 4857 |
|
|
2022
Q2 | $652K | Buy |
203,104
+13,990
| +7% | +$40.6K | ﹤0.01% | 4899 |
|
|
2022
Q1 | $573K | Sell |
189,114
-28,481
| -13% | -$96.3K | ﹤0.01% | 5228 |
|
|
2021
Q4 | $971K | Buy |
217,595
+40,753
| +23% | +$200K | ﹤0.01% | 4862 |
|
|
2021
Q3 | $1.16M | Buy |
176,842
+60,256
| +52% | +$578K | ﹤0.01% | 4625 |
|
|
2021
Q2 | $1.87M | Buy |
116,586
+26,594
| +30% | +$367K | ﹤0.01% | 4272 |
|
|
2021
Q1 | $1.11M | Buy |
89,992
+63,815
| +244% | +$978K | ﹤0.01% | 4517 |
|
|
2020
Q4 | $291K | Sell |
26,177
-15,400
| -37% | -$116K | ﹤0.01% | 4906 |
|
|
2020
Q3 | $202K | Sell |
41,577
-1
| -0% | -$4 | ﹤0.01% | 4910 |
|
|
2020
Q2 | $80K | Sell |
41,578
-5,393
| -11% | -$11.1K | ﹤0.01% | 5022 |
|
|
2020
Q1 | $89K | Buy |
46,971
+17,144
| +57% | +$53.6K | ﹤0.01% | 4959 |
|
|
2019
Q4 | $134K | Buy |
29,827
+15,324
| +106% | +$95.2K | ﹤0.01% | 4998 |
|
|
2019
Q3 | $121K | Buy |
+14,503
| New | +$158K | ﹤0.01% | 4932 |
|
|
2019
Q2 | – | Sell |
-11,274
| Closed | -$172K | – | 5340 |
|
|
2019
Q1 | $172K | Buy |
+11,274
| New | +$187K | ﹤0.01% | 4831 |
|
|
2018
Q4 | – | Sell |
-7,255
| Closed | -$233K | – | 5642 |
|
|
2018
Q3 | $233K | Sell |
7,255
-20,245
| -74% | -$615K | ﹤0.01% | 4842 |
|
|
2018
Q2 | $732K | Buy |
+27,500
| New | +$748K | ﹤0.01% | 4278 |
|
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
Goldman Sachs's STIM Position: Q2 2026 in Review
Goldman Sachs increased its Neuronetics (STIM) stake by 13% in Q2 2026, buying an estimated $44.4K and bringing the position to 264,088 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #5938.
Goldman Sachs first reported a position in STIM in Q2 2018 and has held it in 29 quarters since. The position peaked at $2.32M in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Goldman Sachs held 264,088 shares of Neuronetics worth $343K as of Q2 2026.
- Goldman Sachs bought 30,498 Neuronetics shares in Q2 2026, an estimated $44.4K.
- Neuronetics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5938 holding.
- Goldman Sachs first reported a position in Neuronetics in Q2 2018 and has held it in 29 quarters since.
- Goldman Sachs's Neuronetics position peaked at $2.32M in Q1 2025.
- 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.